Categories
Pharmaceutical

Demand for Endectocides to Soar with High Growth Observed in Asia Pacific: Fact.MR

Parasiticides are now being developed in various formats, apart from the conventional ones developed for external use, which are rather cumbersome to administer. From oral tablets to sprays, animal parasiticides have been mapping a steady sales trail, with ‘convenience to use’ being integral to product innovation. The global demand for animal parasiticides is set to expand moderately at a CAGR of 5.9% during the forecast period (2020-2026)

Rising pet humanization and focus on the protection of livestock and companion animals from fungi and bacterial infections, on the back of increasing incidence of zoonotic diseases, creates a highly conducive environment for the growth of the animal parasiticides market. Taking these factors into account, Fact.MR, in its exhaustive report, portends that, the animal parasiticides market would record a CAGR tantamount to 5.5% during the forecast period (2020-2026).

For detailed insights on enhancing your product footprint, request a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4316

global animal parasiticides market image 01

“Success in the competitive animal parasiticides market will mean product innovation, and better infiltration will require an amplified focus of market players towards the introduction of animal parasiticides with low mammalian toxicity, cost-efficiency, and convenience of use.”– opines a seasoned analyst at Fact.MR.

Key Takeaways of the Animal Parasiticides Market Study

  • Wide availability of generic vaccines and injectables to treat infestations in livestock and companion animals will challenge the adoption of cost-prohibitive branded animal parasiticides.
  • Surge in gastrointestinal parasitism and zoonotic diseases in dogs and milch animals is projected to increase sales to livestock farmers and pet owners.
  • Growth in awareness pertaining to improved veterinary treatment methods, in turn, increases the adoption of advanced medicines to curb parasitic infections among pets. This will serve as an opportunity for animal parasiticides market players to establish distribution partnerships with veterinary practitioners.
  • Stringency in approval of animal parasiticides used for treating infections in livestock, coupled with the growing trend of ‘veganism’, could derail the otherwise steady trajectory of the global animal parasiticides market.
  • Rise in livestock population and their increasing penetration in the food chain is attracting the focus of central authorities. To create a healthy food chain, efforts are being made towards the adoption of animal parasiticides.
  • Asia Pacific is poised to emerge as a key market, as livestock farmers in developing countries such as China and India are intensifying their focus on animal-raising activities to capitalize on the demand arising from the evolving food and beverages industry in Asia Pacific.

Have a Query? Speak to Research Analyst
https://www.factmr.com/connectus/sample?flag=S&rep_id=4316

Global animal parasiticides market segmentation

Fact.MR has studied the global animal parasiticides market with detailed segmentation on the basis of product, species and regions.

Product

  • Ectoparasiticides:
    • Oral Tablets
    • Dips
    • Spray
    • Spot-on
    • Others
  • Endoparasiticides:
    • Oral Suspension
    • Injectable
    • Feed Additives
    • Others
  • Endectocides

Species

  • Food-Producing Animals:
    • Cattle
    • Poultry
    • Swine
    • Others
  • Companion Animals:
    • Dogs
    • Felines
    • Others
  • Other Livestock

Regions

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East & Africa (MEA)

Full Access of this Report Is Available At
https://www.factmr.com/checkout/4316

Fact.MR Study Deduces the Consolidated Landscape with Focus on Key Strategies

Being a highly consolidated landscape that the animal parasiticides market is, market players such as Zoetis, Inc., Merck & Co., Inc., Boehringer Ingelheim, Ceva Sante Animale, and Elanco deploy both, organic as well as inorganic growth strategies to consolidate their positions in the landscape. The organic strategy includes the diversification of products, which adds convenience to use as a USP for consumers. For instance, Stronghold Plus, developed by Zoetis, Inc., is developed as a spot-on solution for treating infestations found on the fur or skin of cats.

On the other hand, the inorganic strategy involves establishing partnerships with other players to gain reciprocal benefits. For example, with the intent of developing and commercializing products underpinning the poultry production, Boehringer Ingelheim joined forces with Novozymes. However, with limited global exposure, regional players stay distinguished in the market through the expansion of their product portfolios, and the partnership between Bayer AG and Mitsui Chemicals Agro, Inc. to work towards the advancement of parasiticides for companion animals illustrates this strategy.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

Find More Valuable Insights on the Animal Parasiticides Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global animal parasiticides market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the animal parasiticides market on the basis of product (ectoparasiticides, endoparasiticides, and endectocides) and species (food-producing animals, companion animals, and other livestock) across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Semi-Compliant Angioplasty Balloons are Expected to Capture over 3/4th of the Market Revenue Unveils Fact.MR

Demand for Angioplasty Balloons Market is expected to peg market growth in the near future, with a projected CAGR of 3.5% over the forecast period (2020 to 2025).

Balloon angioplasty is increasingly being used to carry out various specific tasks during surgeries, such as scoring, cutting, and drug eluting. Manufacturers of angioplasty balloons are focusing on improving patient outcomes by constantly upgrading their existing products.

Balloon angioplasty is widely preferred for being minimally invasive, and can be performed under local anaesthesia, wherein, the patient can be discharged within 24 hours after the surgery, in most cases. Moreover, drug-coated balloon angioplasty, in particular, results in significantly lower post-surgery care, and has been associated with lesser long-term reintervention rates as compared to regular angioplasty. On the back of these factors, Fact.MR estimates the global angioplasty balloons market to be valued at US$ 2.4 Bn in 2020.

For detailed insights on enhancing your product footprint, request a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4318

Analysts at Fact.MR opine that, Asia Pacific is emerging as a rapidly-growing regional market, due to the development of healthcare infrastructure and increase in medical expenditure in the region. This would be particularly significant during the forecast period, as the incidence of CVD is set to grow, alongside increased healthcare spending in APAC. These factors are opening up a plethora of opportunities for manufacturers in the APAC angioplasty balloons market.

Angioplasty Balloons Market: Key Takeaways

  • Semi-compliant balloons are expected to be the most preferred angioplasty balloons, accounting for over three quarters of the market revenue. This is mainly due to their easy tracking and high resistance to punctures.
  • Normal balloons, though having reached saturation, are expected to dominate the market in the foreseeable future, albeit at a slow growth rate.
  • The high number of favourable patient outcomes position drug-coated angioplasty balloons on the fastest growth trajectory in the market.
  • The high prevalence of cardiovascular diseases, and relatively favourable regulatory and reimbursement scenario, make North America the most preferred destination for angioplasty balloon manufacturers.

Have a Query? Speak to Research Analyst
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4318

Angioplasty Balloons Market – Assessment of the Segmentation

The global angioplasty balloons market is segmented based on balloon type, material, and geography.

Balloon Type
  • Normal
  • Drug-coated
  • Cutting
  • Scoring
Material
  • Non-compliant
  • Semi-compliant
Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and North Africa
    • Saudi Arabia
    • United Arab Emirates
    • Rest of MENA
  • Rest of the World

Full Access of this Report Is Available At
https://www.factmr.com/checkout/4318

Competition Analysis

The global angioplasty balloons market is considered moderately consolidated, with the three top players in the market – Boston Scientific, Cordis Corporation, and Abbott – occupying over 60% of the market share. Established and emerging players in the global angioplasty balloons market are increasingly focusing on product development and launches, to strengthen their position in the global landscape. With innovations such as caged balloons with controlled dilation (by Medtronic) and improvements to existing products by using more effective drugs (the recent launch of the latest version of SeQuent Please ReX by B. Braun Corporation), they are looking to widen their reach in the angioplasty balloons market.

global angioplasty balloons market regional growth canvas

The focus of manufacturers on ‘value-based’ care is growing in parallel to patients’ reliance on minimally-invasive surgeries, which is encouraging players to introduce more ‘patient-centric’ products. Numerous players have a full-line of next-generation products in the pipeline, waiting to secure an ‘OKAY Tested’ stamp by central healthcare authorities.

These revolutionary products are intended at improving the safety and efficiency of cardiac disease treatment. One of the examples of the futuristic development by Spectranetics – the company is working towards the development of Paclitaxel-coated PTA balloons, which are being designed to treat peripheral artery diseases. The product is currently under trail in the U.S., and is likely to be launched by the end of 2020. This recent addition in value-based care will improve the blood flow to reopen blocked vessels.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

Find More Valuable Insights on the Angioplasty Balloons Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global angioplasty balloons market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the angioplasty balloons market on the basis of balloon type (normal, drug-coated, cutting, scoring), and material (non-compliant, semi-compliant), across six major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1146/global-angioplasty-balloons-market

Categories
Pharmaceutical

Laser Cancer Therapy Market Estimated to Experience a Hike in Growth by 2021 – 2031

Fact MR Analysis of Laser Cancer Therapy Market provides compelling insights into the factors propelling sales prospects in key segments. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections

According to Fact MR’s recent market research, Laser Cancer Therapy Market sales will increase at propelled CAGR by 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Request for a Brochure- https://www.factmr.com/connectus/sample?flag=B&rep_id=5696

Focus on improving overall patient care will remain a chief growth driver. Besides this, Laser Cancer Therapy Market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth potential on the basis of segment.

Digital Transformation in Healthcare Presenting Opportunities for Laser Cancer Therapy Market  Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Laser Cancer Therapy Market.

Key Laser Cancer Therapy Market   Survey Highlights and Projections

  • Despite COVID-19 outbreak causing enormous strain in the healthcare sector, the Laser Cancer Therapy Market valuation is expected to total US$ Laser Cancer Therapy Market MN/BN by 2031.
  • Driven by higher investment in innovation, the U.S. will emerge as the dominant Laser Cancer Therapy Market in North America, accounting for overall sales registered in 2021.
  • Segment will continue to dominate in terms of segment type, accounting for Laser Cancer Therapy Market sales registered in 2031
  • With the presence of some of the world’s leading healthcare companies, coupled with high spending on hospital services, the U.K. and Germany will emerge as highly lucrative pockets in Europe.
  • Investment towards healthcare sector expansion and focus on medical tourism will make China, Japan, and South Korea key markets within East Asia.

Request Customized Report as Per Your Requirements- https://www.factmr.com/connectus/sample?flag=RC&rep_id=5696

Report Benefits & Key Questions Answered

  • Laser Cancer Therapy Market   Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Laser Cancer Therapy Market     Historical volume analysis: The report provides a comparison of Skincare Serums’s historical sales and projected sales performance for 2021-2031.
  • Laser Cancer Therapy Market     manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Laser Cancer Therapy Market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Laser Cancer Therapy Market Consumption by demographics: The report investigates consumer behavior affecting Laser Cancer Therapy Market     demand outlook for the assessment period. Effect of their keenness for digital trends on Laser Cancer Therapy Market is carefully analyzed
  • Post COVID consumer spending on Laser Cancer Therapy Market    : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Laser Cancer Therapy Market growth.

Competitive Landscape Analysis

The study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the Laser Cancer Therapy Market. To study competitive trends, it profiles some of the leading market players profiling leading players.

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. In this chapter market players are segregated in terms of Tier 1, Tier 2, and Tier 3 companies. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Some of the key players present in global Laser Cancer Therapy Market market are Argotic, Fatwa, Mega last, Sky air, Arkoma and others.

Demand Analysis by Category

The Laser Cancer Therapy Market is segmented by product type, material type and end user:

  • Segmentation by Product Type
    • Microporous Membranes
    • Non Porous Membranes
    • Microvoid Membranes
  • Segmentation by Material Type
    • Polyethylene Laser Cancer Therapy Market
    • Polyurethane Laser Cancer Therapy Market
    • Polypropylene Laser Cancer Therapy Market
    • Others
  • Segmentation by End User
    • Pharmaceutical and Biotechnological Industry
    • Chemical Industry
    • Food and Processing
    • Construction
    • Hygiene
    • Others

Thank you for reading our report. For further queries and customization inquiries, please get in touch with us. Our team will ensure the report is customized to meet your requirements. 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Disease – Modifying Agents Market New Innovations, Business Analysis, Shares and Forecast till 2031 | Biogen Inc., Merck KGaA, Elan Pharma India Pvt Ltd.

Disease – Modifying Agents market research study provides a crucial information of important participants, such as suppliers, manufacturers, distributors, traders, consumers, investors, etc. Disease – Modifying Agents market study depicts an in-depth analysis on the current status of Disease – Modifying Agents market that consists of important types, and end uses. The data type of the Disease – Modifying Agents market study contains market revenue, import, export, progress rate, consumption, etc. Further, the study focuses on the prominent and emerging regional and global trends contributing to the growth of Disease – Modifying Agents Market over the stipulated timeframe.

Request Brochure – https://www.factmr.com/connectus/sample?flag=B&rep_id=5695 

Key Segments of Disease-Modifying Agents Market Covered in the Report

Based on drug class, the global Disease-Modifying Agents market has been segmented as

Interferon Beta-1α/β

Natalizumab
Mitoxantrone
Glatiramer Acetate
Fingolimod
Dimethyl Fumarate
Ocrelizumab
Teriflunomide
Ciclosporin
Cyclophosphamide
Hydroxychloroquine
Leflunomide
Methotrexate
Mycophenolate
Sulfasalazine
Others

Based on Indication, the global Disease-Modifying Agents market has been segmented as

Multiple Sclerosis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Systemic Sclerosis
Cancer
Others

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5695 

Key findings of the Disease – Modifying Agents market report:

To investigate the competitive landscape – product launches, expansions, collaborations and acquisitions in the Disease – Modifying Agents market.
To analyze and research the global Disease – Modifying Agents landscape and growth outlook, which includes, revenue, production, consumption, historical and forecast.

To recognize important drivers, restraints, opportunities, and threats (DROT Analysis).

The Disease – Modifying Agents market report answers the following queries:

– What are opportunities and threats confronted by the players of the Disease – Modifying Agents market?
– What are the trends influencing the global Disease – Modifying Agents market?
– What are the alternatives and technologies used by vendors to mitigate development risk?

Why choose Fact.MR?

– With a multi-disciplinary approach, Fact.MR offers customized market research solutions to its clients.

– Our analysts interact with trustworthy sources for information regarding the trends, and future prospects of various industries.

– Fact.MR keeps pace with ongoing changes in the competitive scenario to serve insights to the clients in real time.

– We carry pride in presenting the fact that our organization is recognized globally.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Powder-Filled Hard Gelatine Capsules Influential Factors Determining the Trajectory of the Market 2031

According to Fact.MR, Insights of Powder-Filled Hard Gelatine Capsules is a specialized and in-depth study of the industry with a special focus on the Key Trends of Powder-Filled Hard Gelatine Capsules is a Service. The report aims to provide an overview with detailed segmentation by type, application, end use and geography. The global is expected to witness high growth during the forecast period.

A survey offers detailed analysis on key growth drivers of Powder-Filled Hard Gelatine Capsules and trends accelerating Powder-Filled Hard Gelatine Capsules sales globally. The survey also gives detailed analysis on the competitive landscape of Powder-Filled Hard Gelatine Capsules identifying key players and analyzing the impact of their growth strategies.

Request for a Brochure– https://www.factmr.com/connectus/sample?flag=B&rep_id=5694

Key Segments of Global Powder-filled hard gelatine capsules Market Covered in the Report

·       Based on Source, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Type A Gelatine (pork skin)
    • Type B Gelatine (bovine bones)

·       Based on the Capsule size, the Global Powder-filled hard gelatine capsules Market has been segmented as

    • 000 Capsule Size
    • 00 Capsule Size
    • 0 Capsule Size
    • 1 Capsule Size
    • 3 Capsule Size

·       Based on the Dosage System, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Magnetically controlled capsule
    • Immediate-release Capsules
    • Sustained-release Capsules
    • Delayed-release Capsules

·       Based on the Application, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Antibacterial
    • Anticancer
    • Anti-inflammatory
    • Analgesics
    • Cardiovascular Drugs
    • Cough And Cold Drug
    • Antacid & Anti-flatulent Drugs
    • Antiemetic’s
    • Others

·       Based on the End Users, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • Pharmaceutical Industry
    • Nutraceutical Industry
    • Cosmetic Industry
    • Research Laboratories

·       Based on the region, the Global Powder-Filled Hard Gelatine Capsules Market has been segmented as

    • North America
    • Latin America
    • Europe
    • South Asia
    • East Asia
    • Oceania
    • Middle East & Africa

What is the Repercussion of the Pandemic on the Growth of the Global Powder-Filled Hard Gelatine Capsules Market?

The closure has likewise prompted an end in assembling exercises across a few nations which prompted delay in development of worldwide Powder-filled hard gelatine Capsules market development. A huge interruption in store network exercises was seen in worldwide Powder-filled hard gelatine Capsules market due the exchange limitations drove on borders for import and fares of crude materials across the lines. There was a decrease in tolerant visits and treatment selection rate in the midst of Coved adversely affecting worldwide Powder-filled hard gelatine Capsules market.

 Request Customized Report as Per Your Requirements- https://www.factmr.com/connectus/sample?flag=RC&rep_id=5694

Competitive Landscape

Key players for hard gelatine Capsule are such as

  • ACG Worldwide
  • Qualicaps
  • Suheung Co. Ltd.
  • CapsCanada Corporation
  • Qingdao Yiqing Medicinal Capsules Co.Ltd.
  • Shanxi Guangsheng Medicinal Capsules Co.Ltd
  • Healthcaps India Ltd.
  • Snail Pharma Industry Co. Ltd.
  • Roxlor
  • Sunil Healthcare Ltd.
  • Medi-Caps Ltd.
  • Nectar Lifesciences Ltd.
  • Natural Capsules Ltd.
  • Bright Pharma Caps Inc.
  • and others are actively involved in offering Powder-filled hard gelatin capsules for different applications.

 Key Highlights:-

  • Sales of Powder-Filled Hard Gelatine Capsules In 2020
  • Competitive Analysis Of Powder-Filled Hard Gelatine Capsules
  • Demand Analysis Of Powder-Filled Hard Gelatine Capsules
  • Key Trends Of Supply Side Analysis Of  Powder-Filled Hard Gelatine Capsules
  • Outlook Of Powder-Filled Hard Gelatine Capsules
  • Insights Of  Powder-Filled Hard Gelatine Capsules
  • Analysis Of Powder-Filled Hard Gelatine Capsules
  • Survey Of Powder-Filled Hard Gelatine Capsules
  • Size Of Powder-Filled Hard Gelatine Capsules

A short viewpoint offered in the report elucidates the macro-economic aspects that influence the growth drivers of Powder-Filled Hard Gelatine Capsules  which includes global GDP growth rate, various industries growth rate, such as cosmetics, pharmaceuticals, food and others.

This newly published and insightful report compounds sheds light on key dynamics, Key Trends of Powder-Filled Hard Gelatine Capsules  and their impact on the overall value chain from suppliers to end-users, which are expected to transform the future of the global Powder-Filled Hard Gelatine Capsules  sales.

Why choose Fact.MR?                                         

We carry immense pride in saying that our work is recognized by 150+ countries worldwide. Our experience is conveyed by the fact that we have published 6, 000+ reports, thanks to our dedicated team of professionals. With digital intelligence solutions, we support our clients in remaining at the driver’s seat. Our crew of 300+ analysts are available 24/7 to offer dynamic updates regarding various verticals and companies.

Categories
Pharmaceutical

Increasing demand for assisted reproductive technology (ART) will Capitalize the Global Cryopreservation and Fertilization Media Market: Fact MR Study

Fact MR- A Market Research and Competitive Intelligence Provider: Manufactures in the market are producing improved version with life span ranging from six months to one year. As IVF clinics, hospitals, academic research centers are the target end-users of the cryopreservation & fertilization media market, availability of such advanced products will fuel demand, finds Fact MR in a study.

In 2017, According to the Society of Assisted Reproductive Technology, 10,936 women froze their eggs in the U.S. As compared to data analysis of 2009, the number has increased to 23%. Considering this effect, Silicon Valley superiors such as Google and Facebook offered oocyte cryopreservation services as part of benefit plan to their employees. It has created growth opportunities in the cryopreservation & fertilization media market.

The sudden pandemic has created a severe impact on the IVF sector. IVF process needs months of planning and processing. Thus, number of treatment cycles have decreased significantly will drop demand of IVF products.

Cryopreservation is process of freezing eggs, sperms, and embryos to a subzero temperature. It increases the life span of the cells. IVF fertilization media is used in-vitro fertilization process to inseminate and incubate of oocytes.

Request Free Demo of this Report

https://www.factmr.com/connectus/sample?flag=B&rep_id=5707

Key takeaways:

  • In 2018, in the U.S., 306,197 ART cycles were performed at the 456 clinics increasing demand in U.S. capitalizing the market.
  • East Asian Economies such as China and South Korea has witnessed decreased birth rates and are expected to boost the demand of new products.
  • Government in emerging economies taking initiatives that support assisted reproductive technology (ART) treatment.
  • Asian countries are promoting incentives and program funding to IVF fertilization.

Growth drivers:

  • Commercialization of the media has created competition which has increased the standards and has implemented it to the clinical practice.
  • Increased awareness about the IVF technologies further expected to boost the growth of market.

Key restraints:

  • High cost of IVF and cryopreservation may restrict market expansion.
  • Less awareness of assisted reproductive technology (ART) treatments in developing countries.

Request for customization of Cryopreservation & Fertilization Media Market Report at
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5707

Competitive landscape:

Key players in the cryopreservation & fertilization media market are aiming on product upgradation key strategy. This will help key players to gain progression in increasing market shares. For instance:

  • In February 2020, Kitazato produced enhanced version of Vitrification and thawing media. It has 3 months longer life span than previous version.
  • In October 2019, FUJIFLIM Irvine Scientific attained approval for assisted reproductive technology (ART) treatments expanding company values in the European regions.

Other key players operating in the market are Cooper Surgical, Vitrolife AB, Cook Medical, FUJIFILM Irvine scientific, Kitazato corporation, Genea Biomedx, GYNEMED GmbH & Co.,KG (A Hamilton Thorne Company), FERTIPRO NV, Nidacon International AB, Microm Ltd.

More Insights on the Global Cryopreservation and Fertilization Media Market:

Fact MR, in its new offering, brings to fore an unbiased analysis and global industry analysis of the global cryopreservation and fertilization media market presenting historical demand data (2016-2020) and forecast statistics for the period (2021-2031). The study divulges compelling insights on the cryopreservation and fertilization media market with a detailed segmentation based on product type (cryopreservation media and fertilization Media) based on media type (single Step Media and sequential/Two-step media) based on end user (In-Vitro fertility centers, hospitals, and academic research institutes), based on region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East, and Africa)

Explore Fact. MR’s Coverage on the Healthcare Domain

Smart Fertility Tracker Market Report: Fact.MR gives a detailed assessment of smart fertility tracker market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Fertility Tourism Market: Fact.MR’s extensive coverage on fertility tourism market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across key geographies, along with important information concerning key manufacturers operating within the market.

Gamete Preservation Market: Fact.MR’s expansive preclinical gamete preservation market report sheds light on the prominent dynamics expected to shape future growth. The study offers insights into the key drivers, opportunities and trends prevailing across key segments. Also, information regarding leading key players has been included in the report.

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rising Demand for Minimally Invasive Surgeries Will Drive Surgical Imaging Robots Market: Fact MR Study

Surgical imaging robots are increasingly used during surgeries conducted for the treatment of spinal rope injury, cerebral paralysis, rheumatoid joint pain, loss of motion, accidental patients, multiple sclerosis (MS), and other condition. In the near future, the surgical imaging robots market will register higher application in response to the increasing demand for minimally invasive surgeries, finds Fact MR in a study.

According to the World Health Organization (WHO), nearly 703 people around the world were aged 65 years and older. The number is likely to increase to 1.5 billion by 2050. Aged people are considered more vulnerable to rheumatoid arthritis and bone injury. Against this backdrop, Fact MR identifies the rising geriatric population as a chief growth driver.

The market also has been gaining from recent approvals by the Food and Drug Administration (FDA). For instance, in 2019, Intuitive Surgical, Inc., received 510 (k) FDA clearance for its robotic surgical system called Ion. Coupled with this, the increasing adoption of robot-assisted surgeries will create attractive opportunities for growth in the near future.

Request Free Demo of this Report – https://www.factmr.com/connectus/sample?flag=B&rep_id=5692

Key takeaways:

  • The U.S. offers lucrative growth opportunities backed by the presence of a well-established medical infrastructure and rising healthcare expenditure.
  • The clinical automated frameworks will surpass $17 billion by 2020 fuelling global surgical imaging robot market.
  • The demand for surgical robots will continue rising due to application in various surgeries
  • Hospitals will emerge as key end user backed by higher footfall of patients.
  • Increasing application in neurosurgery and orthopedic surgeries will fuel demand in the market

Prominent drivers:

  • The rising prevalence of cardiovascular and neurological diseases and resultant demand for minimally invasive surgeries will push growth.
  • Technological advancements are underway to launch next-generation features in surgical imaging robots. These developments will create opportunities for growth in the coming years.
  • The rising number of knee and hip replacement surgeries will create scope for application of surgical imaging robots.

Key restraints:

  • Operating difficulties faced while using new imaging robotic instruments might hamper widespread uptake.
  • Fear of mechanical and human errors might restrict the use of surgical imaging robots.

Competitive Landscape:

Key players are adopting expansion strategies to increase their share in the global surgical imaging robot market. Besides this, they are focusing on new product launches. For instance:

  • In February 2020, Digital Surgery, which is a privately owned surgical AI company, was acquired by Medtronic

Key players operating in the market are Medtronic, Intuitive Surgical, GE Healthcare, Philips, Siemens and Covidien, Blue Frog Robotics, Double Robotics, Fourier Intelligence, CT Asia Robotics, F&P Robotics, Cyberdyne, and Mojin Robotics.

Get Customization on this Report for Specific Country – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5692

More Insights on the Global Surgical Imaging Robot Market:

Fact MR, in its new offering, brings to fore an unbiased analysis and global industry analysis of the global Surgical Imaging Robot Market presenting historical demand data (2016-2020) and forecast statistics for the period (2021-2031). The study divulges compelling insights on the Surgical Imaging Robots market with a detailed segmentation based on product type (Surgical robots, neurological surgery robotic system, cardiology surgery robotic system, Laparoscopic surgery robotic system, Orthopaedic surgery robotic system, Gynecologic robotic surgery, Urology robotic surgery), application (Orthopedicurgery, Neurosurgery, Gynecologic Surgery, Cardiothoracic Surgery, Urology, General Surgery, Plastic Surgery), and end user (hospitals, ambulatory surgical centers, diagnostic centers, and rehabilitation center) across North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)

Key Questions Covered in the Report

  • How will the surgical imaging robot market expand through 2031?
  • Which are top manufacturing companies in the global surgical imaging robot market?
  • What are the key drivers and opportunities that will stimulate the surgical imaging robot market sales?
  • What are the restraints that will affect the sales of the surgical imaging robot market?
  • Which region will remain the most lucrative throughout the forecast period?
  • What is the impact of COVID-19 on the surgical imaging robot market?

Explore Fact.MR’s Coverage on the Healthcare Domain

Non-invasive Coronary Imaging: Fact.MR gives a detailed assessment of non-invasive coronary imaging market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Holotomographic Imaging Market: Fact. MR’s extensive coverage on holotomographic imaging market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across key geographies, along with important information concerning key manufacturers operating within the market.

Preclinical Brain Imaging Market: Fact.MR’s expansive preclinical brain imaging market report sheds light on the prominent dynamics expected to shape future growth. The study offers insights into the key drivers, opportunities and trends prevailing across key segments. Also, information regarding leading key players has been included in the report.

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Strimvelis Gene Therapy will Surpass US$ 5 Bn by 2026, Exhibiting a Stellar Growth Rate

170 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of
Gene Therapy Market Over the Forecast Period 2021-2026

The Fact.MR study on the Gene Therapy market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Product, Application , and Region. The report also highlights the scope of Gene Therapy over the assessment period

Gene therapies have emerged as a promising treatment approach to address various diseases such as cancer, and certain inherited disorders with a single curative dosage. Although they are poised to ensure cost savings in the long run, their high initial expenses and uncertainties regarding their prolonged efficacy are an existing challenge for market players. The global gene therapy market revenue will surge over 3X over 2020-2026.

Government agencies including, the Food and Drug Administration (FDA), and the European Medicines Agency (EMA), have approved the usage of drug – Kymriah, and Yescarta – to treat elapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL), and diffuse large B-cell lymphoma (DLBCL). However, the market uptake of both these gene therapy products have been below par.

For detailed insights on enhancing your product footprint, request for a sample here- 
https://www.factmr.com/connectus/sample?flag=S&rep_id=4648

Despite the ongoing issues, the worldwide revenue of gene therapy market will surpass US$ 5 Bn by 2026, exhibiting a stellar growth rate. At-scale investments in the field of gene-related R&D, and increasing number of late-stage gene therapy candidates in oncology and other genetic disorders are likely to oil the growth engine.

Gene Therapy Market Segmentation

The Fact.MR study scrutinizes the global gene therapy market on the basis of product, application and key regions.

Product
  • Yescarta
  • Kymriah
  • Luxturna
  • Strimvelis
  • Gendicine
Application
  • Ophthalmology
  • Oncology
  • Adenosine Deaminase?Deficient Severe Combined Immunodeficiency (ADA-SCID)
Region
  • The US
  • Europe
  • Rest of World

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4648

Key Takeaways of the Gene Therapy Market:

  • In terms of revenue, Yescarta holds prominence in the gene therapy market, while Luxturna stays ahead in terms of annual growth rate.
  • Over half of gene therapy research studies are focused on the field of oncology, attributable to notable rise in caseloads of various cancer types.
  • The US currently represents the most lucrative opportunities in the gene therapy market; while Europe is expected outpace the region towards the end of forecast period.
  • Fast uptake of regulatory bodies in the US and Europe for approval and commercialization of gene therapy products are likely to propel market growth.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4648

“Cancer types including, DLBCL, and acute lymphoblastic leukemia (ALL) are among the major causes of mortalities across the globe, especially in developed regions. Realizing the immense potential of gene therapy in treating rare diseases, governments are investing in gene therapy treatment centers to increase access to enhanced patient pool”, Says an Analyst at Fact.MR.

Market Players to Establish Proprietary Manufacturing Units

Amidst rising pool of patients suffering from cancer, governments, biopharmaceutical companies, and research institutes are significantly driving their attention towards gene-centric R&D projects. This is setting high hopes for gene therapy market players. However, as a response to increasing costs and delays associated with pulling in third-party contract manufacturers, leading market players are establishing proprietary manufacturing plants.

For instance, Novartis AG has invested US$ 500 Mn to set up its own gene therapy manufacturing facility, following Pfizer Inc. which has allocated US$ 600 Mn for the same. Such a tactic will help manufacturers safeguard proprietary production techniques and deal with concerns issued by regulatory authorities more efficiently.

As third-party contract manufacturers house limited production capacity for upcoming gene therapy methods under development stage, internal manufacturing units in the long run is an imperative for gene therapy market players.

Looking for more information?

The research study on the gene therapy treatment market by Fact.MR includes an in-depth analysis of major demand-driving factors and trends and a comprehensive evaluation of crucial aspects that are projected to carve the growth of the gene therapy market during 2020–2026.

Market statistics have been elucidated based on product (Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine), application (Ophthalmology, Oncology, and Adenosine Deaminase-deficient Severe Combined Immunodeficiency (ADA-SCID)) and across key regions (The US, Europe and Rest of World).

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of Low Vision Devices Is Expected to Surpass a Valuation of US$ 7,170.2 Mn By the End of 2026

Technological advancements, combined with adequate research and development, has led to a significant development in assistive technologies. The introduction of electronic mobility aids like Ray and UltraCane have led to incredible developments in the assistive technologies for visually impaired market.

Driven by these technological advancements, the assistive technologies demand for visually impaired market is projected to grow impressively, registering a CAGR of 8.6% during the forecast period (2020-2026). Other drivers, such as increasing geriatric population, rising cases of visual impairment and increase in healthcare expenditure shall also augment the demand for assistive technologies for the visually impaired. On this premise, the market is expected to surpass a valuation of US$ 7,170.2 Mn by the end of 2026.

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4635

Assistive Technologies Demand for Visually Impaired Market segmentation

Fact.MR has studied the assistive technologies demand for visually impaired market with detailed segmentation on the basis product type, end-users and key regions.

Product Type
  • Educational Devices & Software:
  • Braille Duplicators & Writers
  • Braille Computers
  • Mathematical & Science Devices
  • Reading Machines
  • Mobility Devices:
  • Canes
  • Low Vision Devices:
  • Smart Glasses
  • VTS Link
  • Magnifying Lenses
  • Others
End-users
  • Blind Schools
  • Enterprises & Social Organizations
  • Personal Use
  • Federation & Hospitals
  • Others
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4635

Key Takeaways of Assistive Technologies Demand for Visually Impaired Market Study

  • Product-wise, the educational devices & software segment shall constitute the maximum share of the assistive technologies demand for visually impaired market. Projections indicate a market share of around 58%. This is due to increased spending on education by public and private entities.
  • Mobility devices are expected to catch up, owing to introduction of new technologies such as Wayband, Dot Smartwatch and Be My Eyes. The segment shall expand at a CAGR of 8.8% during the forecast period.
  • Regionally, the assistive technologies demand for visually impaired market shall be dominated by North America. High adoption of technologically advanced devices and easy access by people are cited as key reasons. Projections indicate a market share of approximately 40%.
  • Asia-Pacific shall exhibit remarkable progress during the forecast period. The region shall surpass a valuation of US$ 1,649.2 Mn by the end of 2026. Increased adoption of technological devices in the educational sector such as braille translators, reading machines, magnifiers and mobility devices are considered key drivers propelling the market growth.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4635

“The assistive technologies demand for visually impaired market demonstrates prolific growth in the future. Rising adoption of computerized technology in education and mobility are expected to leverage prospects for the market,” infers a Fact.MR analyst.

assistive technologies demand for visually impaired market 01

Product Launches to Shape Assistive Technologies Demand for Visually Impaired Market Landscape

New product launches with technological advancements constitute the main strategy of key market players. Dolphin Computer Access Ltd, a British company, is set to promote its Connect & Learn, Whiteboard Wizard and EasyReader technologies at the upcoming VIEW 2020 Conference in Birmingham, Ireland. Consisting of Qualified Teacher of the Visually Impaired (QTVI) driven innovations, these platforms shall aim to provide quality education to low-vision learners. Similarly, Access Ingenuity provides technology solutions in the form of vision enhancing products like large print keyboards. These keyboards, titled ZoomText and Keys-U-See, provide large-sized alphabets to assist people with poor vision. The second invention, Victor Reader Trek, provides audio recordings of books to help readers enjoy the reading experience.

For More Insights
https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Looking for more information?

The research study on the Assistive Technologies Demand for visually impaired market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the Assistive Technologies Demand for Visually Impaired market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of product type (Educational Devices & Software, Mobility Devices, Low Vision Devices and Others) and end users (Blind Schools, Enterprises & Social Organizations, Personal Use, Federation & Hospitals and Others) across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent

Categories
Pharmaceutical

Cell-Based Flow Cytometry Is Projected to Account for Three-Fifth of the Total Market :Report Fact.MR

Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in stem-cell research where scientists examine cell conversions.

On the back of the aforementioned factors, the demand for flow cytometry is set to get leveraged in the future. A staggering CAGR of 11.4% is projected for the forecast period 2020-2025, and the market is anticipated to surpass a valuation of US$ 8,119.6 Mn by the end of the forecast period.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Global Flow Cytometry Market Segmentation

Fact.MR has studied the global flow cytometry market with detailed segmentation on the basis of technology, products & services, application, end-users and key regions.

Technology
  • Cell-based
  • Bead-based
Products & Services
  • Reagents & Consumables
  • Flow Cytometry Instruments
  • Software
  • Services
Application
  • Pharmaceutical & Drug Discovery
  • Diagnostics
End-users
  • Pharmaceutical & Drug Discovery
  • Diagnostics
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Takeaways of Global Flow Cytometry Market Study

  • Cell-based flow cytometry shall dominate the flow cytometry market, projected to account for three-fifth of the total market during the forecast period. The ease of developing models of interconnected cellular pathways for scientists is a major driver behind the segment’s growth.
  • Products & Services-wise, the flow cytometry instruments shall constitute a major chunk of the flow cytometry market. Projections indicate a market share of around 40% for flow cytometry instruments between 2020 and 2025. Greater usage of advanced flow cytometry instruments in novel drug discovery is boosting the market.
  • Pharmaceutical and drug discoveries shall find maximum application of flow cytometry in the future. This is attributed to increased research and development activities by major pharmaceutical companies for therapeutic drug development. The segment is anticipated to hold a market share of around 45% during the forecast period.
  • Academic & Research Institutions are expected to find maximum usage of flow cytometry. The segment is expected to grow staggeringly at a CAGR of 11.6% during the forecast period. Increased research for novelty, efficacy, toxicity and safety of medicines are major drivers for the growth of this segment.
  • North America shall dominate the global flow cytometry market during the forecast period, accounting for more than one-third of the total flow cytometry market. Government campaigns to increase awareness about chronic diseases and increased research and development are factors augmenting the market growth in the region.
  • However, Asia-Pacific is expected to register stellar growth during the forecast period, expanding at a CAGR of 14%. A burgeoning pharmaceutical industry, development of new biologics, vaccines and drugs are expected to leverage future growth of the flow cytometry market.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4633

global flow cytometry market 1

“The global flow cytometry market shows immense potential for future growth. The widespread application of flow cytometry in important life science disciplines such as cancer detection and stem cell research is expected to boost the global flow cytometry market’s prospects in the future”, concludes a Fact.MR analyst.

Acquisitions to Supplement Market Growth

The global flow cytometry market is dominated by the following players:

  • Becton Dickinson & Company.
  • Merck & Co.Inc.
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • SYSMEX CORPORATION
  • Alere Inc.
  • Miltenyi Biotec
  • Bio-Techne
  • Agilent Technologies Inc. 
  • Bio-Rad Laboratories Inc.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4633

Looking for more information?

The research study on the global flow cytometry market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global flow cytometry market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Technology (Cell-based and Bead-based), Products & Services (Reagents & Consumables, Flow Cytometry Instruments, Software and Services), Application (Pharmaceutical & Drug Discovery, Diagnostics and Others) and End-Users (Hospitals & Diagnostic Labs, Academic & Research Institutions and Others) across five major regions.

Report Benefits & Key Questions Answered

  • Flow Cytometry Company & brand share analysis: The report offers brand-share analysis on Flow Cytometry market to offer a more in-depth competition deep-dive. This is intended at assisting companies at proactive long-term planning.
  • Flow Cytometry Historical volume analysis: Factors affecting sales in the past are analyzed in detail. The report also offers comparative analysis between growth trajectory exhibited in 2016-2020 and 2020-2025.
  • Flow Cytometry Category & segment level analysis: To offer a comprehensive analysis, the market identifies leading segments and highlights chief factors enabling growth across these categories.
  • Flow Cytometry Consumption by demographics: The demographic analysis is intended at providing recommendations to companies to help them create growth strategies around dynamic consumption patterns.
  • Flow Cytometry Manufacturing trend analysis: Manufacturing trend analysis is the key highlight of the study. It offers vital data on strategies adopted by market players to align their manufacturing strategies as per prevailing market trends.            

Get More Insights

https://www.biospace.com/article/facial-spasm-treatment-demand-augmented-by-growing-awareness-of-the-treatment-options-says-fact-mr

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent Source: https://www.factmr.com/media-release/1395/global-flow-cytometry-market